Blog

Incysus to Present Scientific Overview at the 2018 CAR-T Congress USA Meeting – GlobeNewswire (press release)


GlobeNewswire (press release)

Incysus to Present Scientific Overview at the 2018 CART Congress USA Meeting
GlobeNewswire (press release)
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) — Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today announced the presentation of a scientific overview of

2018-03-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.